Clinical Trial Update: Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effects of the tiotropium/olodaterol combination on exercise endurance and lung hyperinflation in patients with chronic obstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tiotropium + Olodaterol (tiotropium/olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2015-09-15